BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8590392)

  • 21. [Are seroprevalence studies useful in Lyme disease?].
    Díaz-Míguez D; Fernández-Fernández F; Sesma P; Rodríguez-Mayo MD
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):460-1. PubMed ID: 8260522
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood donor Borrelia burgdorferi sensu lato seroprevalence and history of tick bites at a northern limit of the vector distribution.
    Hvidsten D; Mortensen L; Straume B; Arsenovic MG; Pedersen AB; Lyngås G; Gray JS; Grude N
    APMIS; 2017 Aug; 125(8):717-724. PubMed ID: 28612350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to Borrelia burgdorferi in sheep and goats. Alto Adige-South Tyrol, Italy.
    Ciceroni L; Simeoni J; Pacetti AI; Ciarrocchi S; Cacciapuoti B
    New Microbiol; 1996 Apr; 19(2):171-4. PubMed ID: 8722314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of Lyme borreliosis: non-specific serological reactions with Borrelia burgdorferi sonicate antigen caused by IgG2 antibodies.
    Seppälä IJ; Kroneld R; Schauman K; Forsen KO; Lassenius R
    J Med Microbiol; 1994 Apr; 40(4):293-302. PubMed ID: 8151682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between neurologic disease and Borrelia burgdorferi antibodies in 800 paired serum/cerebrospinal fluid samples].
    Kölmel HW; Neumann P; Lange R
    Nervenarzt; 1992 Oct; 63(10):619-24. PubMed ID: 1436252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The outcome of Lyme borreliosis in children.
    Aberer E; Kehldorfer M; Binder B; Schauperi H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of antibodies to Borrelia burgdorferi in sarcoidosis.
    Arcangeli G; Calabro S; Cisno F; Zambotto FM; Drigo R; Ferraresso A
    Sarcoidosis; 1994 Mar; 11(1):32-3. PubMed ID: 8036340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of Lyme disease in gray wolves from Minnesota and Wisconsin.
    Thieking A; Goyal SM; Bey RF; Loken KI; Mech LD; Thiel RP; O'Connor TP
    J Wildl Dis; 1992 Apr; 28(2):177-82. PubMed ID: 1602567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of antibodies to Borrelia burgdorferi in European bison (bison bonasus) from Białowieza Primeval Forest.
    Siński E; Gill J; Rijpkema S
    Rocz Akad Med Bialymst; 1996; 41(1):111-6. PubMed ID: 8673795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seasonal prevalence of antibodies against Borrelia burgdorferi in Białowieza inhabitants.
    Flisiak R; Wiercińska-Drapało A; Kalinowska A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):96-102. PubMed ID: 8673812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Informational value of the prevalence of antiborrelia antibodies in a healthy and at risk population].
    Bartůnĕk P; Mrázek V; Varejka P; Sklenár T; Bína R; Listvanová S; Janovská D
    Epidemiol Mikrobiol Imunol; 2000 Feb; 49(1):4-10. PubMed ID: 10802944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of vectors for Borrelia burgdorferi and Lyme seropositivity in Sivas region].
    Güneş T; Poyraz O; Kaya S; Gençer L; Alim A
    Mikrobiyol Bul; 2005 Oct; 39(4):503-8. PubMed ID: 16544552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses to borrelial VlsE IR6 peptide variants.
    Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
    Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens.
    Fawcett PT; Gibney KM; Rose CD; Dubbs SB; Doughty RA
    J Rheumatol; 1992 Apr; 19(4):582-7. PubMed ID: 1593581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of serum antibodies against Borrelia burgdorferi with some commercially available serological tests.
    Melby K; Steinbakk M; Jensenius M; Figenschau KJ
    NIPH Ann; 1990 Dec; 13(2):37-44. PubMed ID: 2093855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG seroprevalence of Lyme borreliosis in the population of the Aland Islands in Finland.
    Carlsson SA; Granlund H; Nyman D; Wahlberg P
    Scand J Infect Dis; 1998; 30(5):501-3. PubMed ID: 10066053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody reactivity to Borrelia burgdorferi sensu stricto antigens in patients from the Brazilian Amazon region with skin diseases not related to Lyme disease.
    Santos M; Ribeiro-Rodrigues R; Lobo R; Talhari S
    Int J Dermatol; 2010 May; 49(5):552-6. PubMed ID: 20534091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tick-borne borreliosis in the archipelago of southern Sweden.
    Berglund J; Eitrem R
    Scand J Infect Dis; 1993; 25(1):67-72. PubMed ID: 8460352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic evidences suggesting the presence of Borrelia burgdorferi infection in Mexico.
    Gordillo G; Torres J; Solorzano F; Cedillo-Rivera R; Tapia-Conyer R; Muñoz O
    Arch Med Res; 1999; 30(1):64-8. PubMed ID: 10071428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.